Attached files

file filename
S-1/A - AMENDMENT TO FORM S-1 - Cytosorbents Corpv301357_s1a.htm
EX-23.1 - EXHIBIT 23.1 - Cytosorbents Corpv301357_ex23-1.htm

 

February 6, 2012

 

CytoSorbents Corporation

7 Deer Park Drive, Suite K

Monmouth Junction, New Jersey 08852

 

Gentlemen:

 

You have requested our opinion, as counsel for CytoSorbents Corporation, a Nevada corporation (the "Company"), in connection with the registration statement on Form S-1 (the "Registration Statement"), under the Securities Act of 1933 (the "Act"), filed by the Company with the Securities and Exchange Commission.

 

The Registration Statement relates to an offering of 39,634,615 shares of the Company’s common stock.

 

We have examined such records and documents and made such examination of laws as we have deemed relevant in connection with this opinion. No opinion is expressed herein as to any laws other than the State of Nevada of the United States. This opinion opines upon Nevada law including the statutory provisions, all applicable provisions of the Nevada Constitution and reported judicial decisions interpreting those laws.

 

Based on our examination mentioned above, we are of the opinion that the securities being sold pursuant to the Registration Statement are duly authorized and will be, when issued in the manner described in the Registration Statement, legally and validly issued, fully paid and non-assessable.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to our firm under the caption “Experts” in the Registration Statement. In so doing, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Act and the rules and regulations of the Securities and Exchange Commission promulgated thereunder.

 

Very truly yours,

 

ANSLOW & JACLIN, LLP

 

 

 

195 Route 9 South, Suite 204, Manalapan, New Jersey 07726

Tel: (732) 409-1212 Fax: (732) 577-1188